Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the sentrant device.The exact size of the device is unknown.Survey results from a cardiovascular surgeon in practice 20 years, who has used the device 200 times in total of which all of those times were in the last 12 months.During use of the sentrant, the following complications were encountered in the last 12 months; allergic response to materials (20 occasions) <(>&<)> infection (on 20 occasions) half of these allergic response and infection events were assessed by the physician to be related to the device.The physician assessed the infection and the allergic response to materials events, as very concerning,somewhat concerning and not at all concerning.The physician did not know that the allergic response to materials was a potential complication with use of the sentrant but did known infection was a potential issue as noted in the ifu of the device.The physician had the opinion that the sentrant performed as expected when it was used.No further information has or will be provided.
|